Dr Michael Newnham

Dr Michael Newnham

Institute of Applied Health Research
Respiratory Clinical Lecturer

Contact details

Murray Learning Centre
University of Birmingham
B15 2TT

Michael Newnham is a Clinical Lecturer and Registrar in Respiratory Medicine.  His research interests are predominantly focused on pulmonary vascular diseases including pulmonary embolism and chronic thromboembolic pulmonary hypertension. Michael has experience in research methods that include genomics, big data, biostatistics, clinical research trials and risk prediction modelling.


Clinical Lecturer in Respiratory Medicine:

  • PhD in Medicine 2016-2019
  • PGCert in Medical Education 2011
  • MRCP 2009
  • MBChB 2006
  • MSc in Pathological Studies 2005


Michael graduated from the University of Birmingham in 2006, then worked in the West Midlands and commenced Respiratory Medicine training in 2011.  He undertook his PhD at Cambridge University from 2016-2019 investigating genetic associations in chronic thromboembolic pulmonary hypertension.  Michael spent several years working in the pulmonary vascular diseases unit at Papworth Hospital where he retains strong collaborative research links.

Michael has worked at the University of Birmingham as a clinical lecturer since September 2018 as part of Dr Alice Turner’s research group.      



  •  Written Professional Communication component – lecture, teaching, marking and moderation
  • 4th year elective project supervisor
  • Personal mentor for a group of year 1 & 2 students


Research Themes:

  • Diagnostic and prognostic studies in pulmonary vascular disease
  • Genetic associations of pulmonary vascular disease including chronic thromboembolic pulmonary hypertension 
  • Utilising health data in research 


Newnham M, South K, Bleda M, Auger WR, Barbera JA, Bogaard H, . . . Toshner M. The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019.  doi:10.1183/13993003.01805-2018

Rhodes CJ, . . .Newnham M, . . .Wilkins MR. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019; 7(3): 227-238. doi:10.1016/s2213-2600(18)30409-0

Graf S, . . .Newnham M, . . .Morrell NW. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018; 9(1): 1416.  doi:10.1038/s41467-018-03672-4

Guo J, Lodge K, Newnham M, Bunclark K, Toshner M, Morrell NW & Li W. Increased Antielastase Activity in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2018; 59(5): 652-655. doi:10.1165/rcmb.2018-0060LE

Hadinnapola C, . . .Newnham M, . . .Morrell NW. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension. Circulation. 2017; 136(21): 2022-2033. doi:10.1161/circulationaha.117.028351

Newnham M, Hernandez-Sanchez J, Dunning J, Ng C, Tsui S, Bunclark K, . . . Cannon J. Age should not be a barrier for pulmonary endarterectomy in carefully selected patients. Eur Respir J. 2017; 50(6): 1701804  doi:10.1183/13993003.01804-2017

View all publications in research portal